RecruitingNCT05700682

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

Perfusion MRI-targeted Joint Embolization to Diagnose and Treat Neovascularity Associated With Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee: A Prospective Cohort Study


Sponsor

Palo Alto Veterans Institute for Research

Enrollment

120 participants

Start Date

Jul 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In this work the investigators will study the relationship between chronic musculoskeletal pain and abnormal blood flow (neovascularity) around the shoulder, hip and knee. Veterans with as history of chronic shoulder, hip or knee pain and mild/moderate joint degenerative changes will be potential study subjects. Blood flow around joints will be evaluated using perfusion magnetic resonance imaging (MRI). Participants with demonstrably abnormal blood flow around their painful joint will be eligible for enrollment in a pilot study of joint embolization to treat their pain. Participants who choose to not undergo treatment will be re-assessed with MRI after one year to characterize the natural history of joint neovascularity and its relationship to pain.


Eligibility

Min Age: 25 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new approach to treating chronic joint pain in the shoulder, hip, or knee using a minimally invasive procedure called joint embolization — blocking some of the abnormal new blood vessels that grow in painful arthritic joints and are thought to contribute to pain and inflammation. The procedure is guided by a special MRI technique that maps blood flow in and around the joint. You may be eligible if: - You are a US Veteran receiving care through the VA system - You are between 25 and 80 years old - You have had chronic pain in your shoulder, hip, or knee for at least 1 year - You have mild to moderate degenerative joint changes confirmed by imaging - You have tried at least one treatment for your pain (such as physical therapy, NSAIDs, or steroid injections) without adequate relief - A clinical provider has ordered an MRI of your painful joint You may NOT be eligible if: - You had an acute joint injury in the last 12 weeks - You have severe degenerative changes in the joint - You have had a joint replacement or metal implant in the affected joint - You have severe renal disease or are on dialysis - You are currently pregnant - You have a severe allergy to gadolinium or iodinated contrast agents - You have a history of malignancy with life expectancy under one year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEShoulder/Hip/Knee Embolization with Embozene Microspheres

Fluoroscopically-guided arterial embolization of synovitis in the painful shoulder, hip or knee.


Locations(1)

VA Palo Alto Healthcare System

Palo Alto, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05700682


Related Trials